- Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic reviewTamara Castillo-Trivino
Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA
PLoS ONE 8:e66308. 2013..Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS...